首页> 外国专利> PHARMACEUTICAL COMPOSITION OF ATORVASTATIN TABLET AND FENOFIBRIC ACID PELLTS IN CAPSULE

PHARMACEUTICAL COMPOSITION OF ATORVASTATIN TABLET AND FENOFIBRIC ACID PELLTS IN CAPSULE

机译:胶囊中阿托伐他汀片和非诺贝酸药片的药物组成

摘要

The present invention relates to the designs of ebonite capsule formula; And a kind of manufacturing method ebonite capsule formula design, it includes Fenofibric Acid or its pharmaceutically acceptable salt and basifier that wherein the design of ebonite capsule formula, which includes (a) pellet,; (2) weight ratio of the tablet comprising Atorvastatin or its pharmaceutically acceptable salt and crospovidone is 1:2.5∶1:5.5. According to the present invention, ebonite capsule formula design shows excellent dissolution rate and bioavilability, therefore is actually used in treatment hyperlipidemia and hypercholesterolemia. ;The 2015 of copyright KIPO submissions
机译:本发明涉及硬质胶囊配方的设计。一种制造硬质橡胶胶囊配方设计的方法,它包括非诺贝酸或其药学上可接受的盐和碱化剂,其中硬质橡胶胶囊配方设计包括,(a)丸剂; (2)包含阿托伐他汀或其药学上可接受的盐和交聚维酮的片剂的重量比为1∶2.5∶1∶5.5。根据本发明,硬质橡胶胶囊配方设计显示出优异的溶解速度和生物利用度,因此实际上用于治疗高脂血症和高胆固醇血症。 ; 2015年版权KIPO提交文件

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号